Candidate proto-oncogene bcl-3 encodes a subunit-specific inhibitor of transcription factor NF-kappa B

F G Wulczyn1, M Naumann, C Scheidereit

  • 1Otto Warburg Laboratorium, Max Planck Institut für Molekulare Genetik, Berlin, Germany.

Nature
|August 13, 1992
PubMed

Insights

The proto-oncogene bcl-3 encodes a protein that acts as a specific inhibitor for the NF-kappa B p50 subunit. This finding reveals a new regulatory mechanism for NF-kappa B transcription factors involved in cell growth and disease.

Area of Science:

  • Molecular Biology
  • Cellular Biology
  • Oncogenesis

Background:

  • Nuclear factor kappa B (NF-kappa B) and related proteins (p50, p65, c-rel) are transcription factors with unique DNA-binding and dimerization domains.
  • Their nuclear translocation is regulated by cytoplasmic inhibitors, including I kappa B-alpha, I kappa B-beta, and pp40, which target p65 or c-rel.
  • The proto-oncogene bcl-3 is implicated in human B-cell leukaemias.

Purpose of the Study:

  • To investigate the function of the bcl-3 proto-oncogene product in relation to NF-kappa B transcription factors.
  • To determine if bcl-3 acts as a cytoplasmic inhibitor for NF-kappa B subunits.
  • To elucidate the mechanism by which bcl-3 interacts with NF-kappa B.

Main Methods:

  • Analysis of the bcl-3 gene product's function.
  • Investigation of protein-protein interactions between bcl-3 and NF-kappa B subunits.
  • Characterization of the role of the ankyrin repeat domain in bcl-3.

Main Results:

  • The bcl-3 product functions as an I kappa B-like molecule.
  • bcl-3 specifically inhibits the NF-kappa B p50 subunit, unlike other known inhibitors.
  • The ankyrin repeat domain of bcl-3 mediates complex formation with NF-kappa B dimers by contracting the dimerization domain.

Conclusions:

  • The bcl-3 proto-oncogene encodes a novel I kappa B-like inhibitor specific for the NF-kappa B p50 subunit.
  • This interaction regulates NF-kappa B activity and has implications for understanding human B-cell leukaemias.
  • bcl-3 represents a new target for studying NF-kappa B pathway regulation.

Related Concept Videos

Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...